Related Experiment Video
Updated: May 8, 2026
A Surgical Model of Heart Failure with Preserved Ejection Fraction in Tibetan Minipigs
Published on: February 18, 2022
Treatment strategies for the prevention of heart failure
Justin L Grodin1, W H Wilson Tang
1Department of Cardiovascular Medicine, Cleveland Clinic Foundation, 9500 Euclid Avenue, Desk J3-4, Cleveland, OH, 44195, USA.
Insights
Preventing heart failure (HF) involves managing hypertension with sodium restriction and thiazide diuretics, controlling dyslipidemia with statins, and using ACE inhibitors. Avoiding cardiotoxins is also crucial for HF prevention.
Area of Science:
- Cardiology
- Preventive Medicine
- Public Health
Background:
- Heart failure (HF) presents significant morbidity and mortality.
- Preventive strategies are essential for managing the HF epidemic.
- Established risk factors include hypertension, dyslipidemia, and lifestyle choices.
Purpose of the Study:
- To review established and emerging preventive strategies for heart failure.
- To highlight the role of pharmacotherapies and lifestyle modifications in HF prevention.
- To discuss the current limitations and future directions in HF prevention research.
Main Methods:
- Review of existing clinical trial data and epidemiological studies.
- Analysis of the efficacy of antihypertensive, lipid-lowering, and cardioprotective therapies.
- Evaluation of lifestyle interventions and biomarker-guided strategies for HF prevention.
Main Results:
- Hypertension control, particularly with sodium restriction and thiazide diuretics, is key.
- Aggressive statin therapy benefits HF prevention in acute coronary syndrome.
- ACE inhibitors show efficacy in high-risk populations; tight glycemic control's role is complex.
- Avoiding tobacco and cardiotoxins is recommended.
Conclusions:
- Multiple therapeutic avenues exist for heart failure prevention, including pharmacotherapy and lifestyle changes.
- Biomarker-guided interventions show promise but require further research for clinical application.
- Comprehensive management of cardiovascular risk factors is fundamental to reducing HF incidence.
Abstract:
With the astounding morbidity and mortality associated with heart failure (HF), preventive approaches have been explored. Controlling hypertension to prevent HF is well-established, especially with sodium restriction and thiazide-based antihypertensive therapies showing potential advantages. Control of dyslipidemia with aggressive statin therapy is particularly beneficial in preventing HF in the setting of acute coronary syndrome. The HOPE study also established the benefit of ACE inhibitors in the prevention of HF in high-risk subjects. Meanwhile old data supporting tight glycemic control in preventing HF have not been confirmed, suggesting the complexity of diabetic cardiomyopathy. Avoiding tobacco use and other known cardiotoxins are likely helpful. While there has been substantial development in identifying biomarkers predicting future development of HF, therapeutic interdiction guided by biomarker levels have yet to be established, even though it offers hope in modulating the natural history of the development of HF in at-risk individuals.
Related Concept Videos
01:22Heart Failure VI: Adjunct Therapies
01:30Heart Failure V: Medical Management
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
01:30Heart Failure VII: Nursing Interventions
01:30Heart Failure IV: Classification and Diagnostic Evaluation
01:29Cardiomyopathy V: Interprofessional Care